Aurizon Holdings Limited:企業の戦略・SWOT・財務情報

◆英語タイトル:Aurizon Holdings Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C8915
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:輸送・物流
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Aurizon Holdings Limited – Strategy, SWOT and Corporate Finance Report
Summary

Aurizon Holdings Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Aurizon Holdings Limited (Aurizon) is rail freight operator. It offers integrated freight and logistics solutions via rail and road network in Australia. Aurizon transports a wide variety of commodities, including mining, agricultural, industrial, and retail products for diverse clientele. The company moves retail goods and groceries across small and big towns and cities across Australia; and also transports iron ore in the West and several tons of coal to the Eastern ports. The company owns and operates coal rail networks that connect mines with terminals of major ports in Queensland. It has operations in Australia and Singapore. Aurizon is headquartered in Brisbane, Australia.

Scope

- Detailed information on Aurizon Holdings Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Aurizon Holdings Limited in the form of a SWOT analysis
- An in-depth view of the business model of Aurizon Holdings Limited including a breakdown and examination of key business segments
- Intelligence on Aurizon Holdings Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Aurizon Holdings Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Aurizon Holdings Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Aurizon Holdings Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Aurizon Holdings Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Aurizon Holdings Limited: Company Overview 9
Aurizon Holdings Limited: Overview and Key Facts 9
Aurizon Holdings Limited: Overview 9
Aurizon Holdings Limited: Key Facts 9
Aurizon Holdings Limited: Key Employees 10
Aurizon Holdings Limited: Key Employee Biographies 12
Aurizon Holdings Limited: Major Products and Services 14
Aurizon Holdings Limited: Company History 15
Aurizon Holdings Limited: Management Statement 18
Aurizon Holdings Limited: Locations and Subsidiaries 20
Aurizon Holdings Limited: Key Competitors 21
Aurizon Holdings Limited: Company Analysis 22
Aurizon Holdings Limited: Business Description 22
Aurizon Holdings Limited: SWOT Analysis 24
Aurizon Holdings Limited: SWOT Overview 24
Aurizon Holdings Limited: Strengths 24
Aurizon Holdings Limited: Weaknesses 25
Aurizon Holdings Limited: Opportunities 25
Aurizon Holdings Limited: Threats 26
Aurizon Holdings Limited: Corporate Financial Deals Activity 28
Aurizon Holdings Limited: Financial Deals Overview 28
Aurizon Holdings Limited: Top Deals 2014 – 2018YTD* 30
Aurizon Holdings Limited: Divestments 31
Aurizon Holdings Limited: Recent Developments 32
Aurizon Holdings Limited: News and Events Summary 32
Aurizon Holdings Limited: Business Expansion 33
Aurizon Holdings Limited: Business Reorganization 33
Aurizon Holdings Limited: Corporate Governance 34
Aurizon Holdings Limited: Red Flags/Distress Signals 34
Aurizon Holdings Limited: Red Flags/DistressSignals 35
Aurizon Holdings Limited: Strategy and Operations 36
Appendix 37
Contact Us 37
Methodology 37
About MarketLine 38

List of Tables
Table 1: Aurizon Holdings Limited: Key Facts
Table 2: Aurizon Holdings Limited: Key Employees
Table 3: Aurizon Holdings Limited: Company History
Table 4: Aurizon Holdings Limited: Locations and Subsidiaries
Table 5: Aurizon Holdings Limited: Key Competitors
Table 6: Aurizon Holdings Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Aurizon Holdings Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Aurizon Holdings Limited: Top Deals 2014 - 2018YTD*
Table 9: Aurizon Holdings Limited: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 10: Aurizon Holdings Limited: News and Events Summary
Table 11: Aurizon Holdings Limited: Business Expansion
Table 12: Aurizon Holdings Limited: Business Reorganization
Table 13: Aurizon Holdings Limited: Corporate Governance
Table 14: Aurizon Holdings Limited: Red Flags/Distress Signals
Table 15: Aurizon Holdings Limited: Red Flags/DistressSignals
Table 16: Aurizon Holdings Limited: Strategy and Operations

List of Figures
Figure 1: Aurizon Holdings Limited: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Aurizon Holdings Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Aurizon Holdings Limited: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Aurizon Holdings Limited:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EnGeneIC Ltd-製薬・医療分野:企業M&A・提携分析
    Summary EnGeneIC Ltd (EnGeneIC) is a biopharmaceutical company that develops drugs and other therapeutic molecules. The company develops nanocell platform used as a platform for the creation of custom therapies for cancer. Its cyto-immunotherapy platform releases concentrations of RNA-interference m …
  • Intersect ENT Inc (XENT):医療機器:M&Aディール及び事業提携情報
    Summary Intersect ENT Inc (Intersect), formerly Sinexus Inc is a medical device company that offers chronic sinusitis solutions. The company offers steroid releasing implants and mini steroid implants. It provides surgical solutions for patients, disease recurrence with recurrent symptoms. Intersect …
  • Teradyne, Inc.:企業の戦略・SWOT・財務情報
    Teradyne, Inc. - Strategy, SWOT and Corporate Finance Report Summary Teradyne, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Hikma Pharmaceuticals PLC:企業のM&A・事業提携・投資動向
    Hikma Pharmaceuticals PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hikma Pharmaceuticals PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Arris International Plc:企業の戦略・SWOT・財務分析
    Arris International Plc - Strategy, SWOT and Corporate Finance Report Summary Arris International Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • AerCap Holdings NV:企業の戦略・SWOT・財務情報
    AerCap Holdings NV - Strategy, SWOT and Corporate Finance Report Summary AerCap Holdings NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • China National Pharmaceutical Group Corp-製薬・医療分野:企業M&A・提携分析
    Summary China National Pharmaceutical Group Corp (Sinopharm) is a provider of medical and healthcare services. Its core businesses include the distribution, retailing, research and manufacture of healthcare related products. Its product portfolio includes EPI vaccines; biopharmaceutical products; an …
  • Victoria PLC (VCP):企業の財務・戦略的SWOT分析
    Victoria PLC (VCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Invicta Holdings Limited:企業の戦略・SWOT・財務分析
    Invicta Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Invicta Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sonda SA (SONDA):企業の財務・戦略的SWOT分析
    Sonda SA (SONDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Commerce Resources Corp (CCE):企業の財務・戦略的SWOT分析
    Summary Commerce Resources Corp (Commerce Resources) is a minerals exploration and development company that explores for deposits of rare earth elements and rare metals. The company acquires, explores, produces, develops, evaluates mineral resource properties, and others. It explores for niobium and …
  • Sosei Heptares (4565):企業の財務・戦略的SWOT分析
    Summary Sosei Heptares(Sosei) formerly known as Sosei Group Corp, is a biopharmaceutical company that develops and commercializes drugs. The company’s pipeline products include NorLevo, NVA237, QVA149 and SO-1105. Its NorLevo product is an oral emergency contraceptive; and SO-1105 is an antifungal a …
  • Ernst & Young Global Ltd
    Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report Summary Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Praxair, Inc.:企業のM&A・事業提携・投資動向
    Praxair, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Praxair, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Sealed Air Corporation:企業のM&A・事業提携・投資動向
    Sealed Air Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sealed Air Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • JetBlue Airways Corp:企業の戦略・SWOT・財務分析
    JetBlue Airways Corp - Strategy, SWOT and Corporate Finance Report Summary JetBlue Airways Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Mitel Networks Corporation:企業のM&A・事業提携・投資動向
    Mitel Networks Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitel Networks Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Cox Enterprises Inc:企業の戦略的SWOT分析
    Cox Enterprises Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Amyris Inc (AMRS):企業の財務・戦略的SWOT分析
    Summary Amyris Inc (Amyris) formerly Amyris Biotechnologies Inc, is a healthcare product manufacturer that offers integrated renewable products. The company provides alternatives to a range of petroleum-sourced products and rare materials. It offers health and wellness products, clean beauty product …
  • Gavis Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Gavis Pharmaceuticals LLC (GAVIS), a subsidiary of Lupin Ltd is a healthcare products provider that develops, markets and distributes tablets and oral solutions. The company offers products such as cetrizine hydrochloride, clobetasol propionate, dexmethylphenidate hydrochloride, dextroamphet …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆